Primary Site >> Colorectal Cancer

Gene >> CDA

  • 1996
  • 2008
  • 2009
  • 2011
  • 2013
  • 2015
  • 2016
  • 2017
Ref: Expression of cytidine deaminase in human solid tumors and its regulation by 1 alpha,25-dihydroxyvitamin D3.
PMID: 8672545
Ref: Novel blood-based, five-gene biomarker set for the detection of colorectal cancer.
PMID: 18203981
Ref: Gene-specific methylation: potential markers for colorectal cancer.
PMID: 19404924
Ref: Association of RRM1 -37A>C polymorphism with clinical outcome in colorectal cancer patients treated with gemcitabine-based chemotherapy.
PMID: 21220199
Ref: A polymorphism in the cytidine deaminase promoter predicts severe capecitabine-induced hand-foot syndrome.
PMID: 21325291
Ref: Higher capecitabine AUC in elderly patients with advanced colorectal cancer (SWOGS0030).
PMID: 24022189
Ref: Variants in CDA and ABCB1 are predictors of capecitabine-related adverse reactions in colorectal cancer.
PMID: 25691056
Ref: Acquired resistance to decitabine and cross-resistance to gemcitabine during the long-term treatment of human HCT116 colorectal cancer cells with decitabine.
PMID: 26622566
Ref: Portal of medical data models: information infrastructure for medical research and healthcare.
PMID: 26868052
Ref: Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
PMID: 28672935